LIM
Lagoda Investment Management Portfolio holdings
AUM
$177M
This Quarter Return
+5.63%
1 Year Return
+46.81%
3 Year Return
+194.86%
5 Year Return
+427.13%
10 Year Return
+1,154.94%
AUM
$382M
AUM Growth
+$382M
(+2.1%)
Cap. Flow
-$5.21M
Cap. Flow
% of AUM
-1.36%
Top 10 Holdings %
Top 10 Hldgs %
73.67%
Holding
35
New
2
Increased
12
Reduced
14
Closed
4
Top Buys
| 1 |
PTC
PTC
|
$10.6M |
| 2 |
Novo Nordisk
NVO
|
$2.63M |
| 3 |
SNMX
Senomyx, Inc.
SNMX
|
$2.54M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$2.38M |
| 5 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
$2.08M |
Top Sells
| 1 |
Brookfield
BN
|
$22.9M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$2.84M |
| 3 |
Corning
GLW
|
$2.13M |
| 4 |
Allison Transmission
ALSN
|
$2.01M |
| 5 |
Rockwell Automation
ROK
|
$1.3M |
Sector Composition
| 1 | Healthcare | 56.03% |
| 2 | Financials | 14.85% |
| 3 | Technology | 6.9% |
| 4 | Communication Services | 5.76% |
| 5 | Materials | 5.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Pfizer
PFE
$141B
| $54K | 0.01% |
1,617
| – | – |
|
27
AbbVie
ABBV
$372B
| $33K | 0.01% |
491
| – | – |
|
28
Abbott
ABT
$231B
| $31K | 0.01% |
640
| – | – |
|
29
Phillips 66
PSX
$54B
| $25K | 0.01% |
307
-25
| -8% | -$2.04K |
|
30
GSK
GSK
$79.9B
| $11K | ﹤0.01% |
269
-50
| -16% | -$2.05K |
|
31
RTX Corp
RTX
$212B
| $10K | ﹤0.01% |
93
-65
| -41% | -$6.99K |
|
32
Chevron
CVX
$324B
| – | – |
-250
| Closed | -$26K |
|
33
Dominion Energy
D
$51.1B
| – | – |
-140
| Closed | -$10K |
|
|
34
Rockwell Automation
ROK
$38.6B
| – | – |
-11,237
| Closed | -$1.3M |
|
|
35
Brookfield
BN
$98.3B
| – | – |
-426,782
| Closed | -$22.9M |
|